WHO Points to consider in continuous manufacturing of pharmaceutical products (DRAFT)
Title:
WHO Points to consider in continuous manufacturing of pharmaceutical products (DRAFT)
Short Title:
QAS/24.957
Origin/Publisher:
WHO headquarters, Avenue Appia 20, 1211 Geneva 27, Switzerland Telephone: (+ 41 22) 791 21 11, Facsimile (fax): (+ 41 22) 791 3111, Telex: 415 416, Telegraph: UNISANTE GENEVA
Content:
This document presents points to consider for manufacturers implementing CM in the production of pharmaceutical products. The principles contained in this document may be useful where chemicals, excipients used in pharmaceutical products, (APIs), and FPPs are produced by CM. Although the examples given in the document focus on oral solid dosage forms, the principles may be applied to other dosage forms, biologicals and vacci